rs748531024
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_004928.3(CFAP410):c.33_34insAGCTGCACAGCGTGCA(p.Ala12SerfsTer60) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00008 in 1,474,772 control chromosomes in the GnomAD database, with no homozygous occurrence. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R11R) has been classified as Benign.
Frequency
Consequence
NM_004928.3 frameshift
Scores
Clinical Significance
Conservation
Publications
- axial spondylometaphyseal dysplasiaInheritance: AR Classification: DEFINITIVE Submitted by: G2P
- amyotrophic lateral sclerosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- cone-rod dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CFAP410 | NM_004928.3 | c.33_34insAGCTGCACAGCGTGCA | p.Ala12SerfsTer60 | frameshift_variant | Exon 1 of 7 | ENST00000339818.9 | NP_004919.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CFAP410 | ENST00000339818.9 | c.33_34insAGCTGCACAGCGTGCA | p.Ala12SerfsTer60 | frameshift_variant | Exon 1 of 7 | 1 | NM_004928.3 | ENSP00000344566.4 | ||
| CFAP410 | ENST00000397956.7 | c.33_34insAGCTGCACAGCGTGCA | p.Ala12SerfsTer60 | frameshift_variant | Exon 1 of 7 | 1 | ENSP00000381047.3 | |||
| CFAP410 | ENST00000325223.7 | c.33_34insAGCTGCACAGCGTGCA | p.Ala12SerfsTer60 | frameshift_variant | Exon 1 of 7 | 1 | ENSP00000317302.7 | |||
| ENSG00000232969 | ENST00000426029.1 | n.-215_-214insTGCACGCTGTGCAGCT | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000790 AC: 12AN: 151840Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000436 AC: 4AN: 91818 AF XY: 0.0000388 show subpopulations
GnomAD4 exome AF: 0.0000801 AC: 106AN: 1322932Hom.: 0 Cov.: 32 AF XY: 0.0000736 AC XY: 48AN XY: 652506 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000790 AC: 12AN: 151840Hom.: 0 Cov.: 31 AF XY: 0.0000674 AC XY: 5AN XY: 74176 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:3
CFAP410: PVS1, PM2 -
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Observed with a second pathogenic variant in a patient with retinitis pigmentosa in published literature (Carss et al., 2017), although the phase of these two variants was not confirmed; This variant is associated with the following publications: (PMID: 32581362, 28041643) -
This sequence change creates a premature translational stop signal (p.Ala12Serfs*60) in the CFAP410 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CFAP410 are known to be pathogenic (PMID: 23105016, 26167768). This variant is present in population databases (rs748531024, gnomAD 0.02%). This premature translational stop signal has been observed in individuals with retinal dystrophy (PMID: 28041643). ClinVar contains an entry for this variant (Variation ID: 438159). For these reasons, this variant has been classified as Pathogenic. -
Retinal dystrophy Pathogenic:3
- -
- -
- -
Retinitis pigmentosa Pathogenic:2
- -
Clinical significance based on ACMG v2.0 -
CFAP410-related disorder Pathogenic:1
The CFAP410 c.33_34insAGCTGCACAGCGTGCA variant is predicted to result in a frameshift and premature protein termination (p.Ala12Serfs*60). This variant has been reported in individuals with retinitis pigmentosa (see for examples: Carss et al. 2016. PubMed ID: 28041643; Areblom et al. 2023. PubMed ID: 37510321; Table S1, Lin et al. 2024. PubMed ID: 38219857). This variant is reported in 0.017% of alleles in individuals of European (Finnish) descent in gnomAD. Frameshift variants in CFAP410 are an established mechanism of disease. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at